JL&K, Heading to the 2025 International Stroke Conference... Full-Scale Push into the US Market

원본보기 아이콘

Stroke AI specialist JLK (CEO Dongmin Kim) announced on the 23rd that it will participate in the 2025 International Stroke Conference (hereinafter ISC 2025) held at the LA Convention Center in the United States from February 5 to 7 (local time).

At ISC 2025, JLK plans to seek collaboration with medical professionals worldwide and discuss the future of stroke diagnosis and treatment through an exhibition booth and presentation sessions featuring the company’s main product, the artificial intelligence stroke analysis platform ‘MEDIHUB STROKE.’

The company arranged for continuous display of JLK solutions via large screens located at the center and sides of the booth. Additionally, the company logo and QR codes were placed at the top of the booth to enhance visibility and accessibility.

Considering the nature of this exhibition, where global medical institution representatives gather in one place, it is known that an interactive booth will be operated. There will be a corner where visitors can directly compete with the AI stroke analysis platform ‘MEDIHUB STROKE,’ aiming to increase visitor participation.

At the triangular prism-shaped center, medical staff can view actual stroke patient imaging data, predict prognosis, and then compare their results with those provided by the AI. The strategy is to allow medical professionals to directly experience the company’s solution and personally feel the convenience and accuracy of AI technology.

In a special session, the convenience and technological capabilities of JLK’s AI solution, confirmed in clinical settings, will be showcased. A research abstract presentation is scheduled under the theme “Improving the detection sensitivity of high-difficulty acute cerebral infarction lesions on diffusion-weighted imaging (DWI) using the JLK AI solution JBS-01K (JLK-DWI).”

JLK CEO Dongmin Kim stated, “This ISC 2025 participation is meaningful as it is the first international event JLK is attending since beginning to receive FDA approval for its stroke solutions in the United States,” adding, “We recognize this event as an important milestone to launch our full-scale entry into the U.S. market and will do our utmost to introduce JLK’s solutions to more medical institutions.”

Meanwhile, ISC 2025 is an academic event jointly hosted by the American Heart Association and the Stroke Association. It is the most prestigious international event where global stroke scholars and clinical experts gather to discuss research results aimed at brain health through the development of stroke treatment technologies.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.